欧美精品在线第一页,久久av影院,午夜视频在线播放一三,久久91精品久久久久久秒播,成人一区三区,久久综合狠狠综合久久狠狠色综合,成人av一区二区亚洲精,欧美a级在线观看

China Focus: China strives for affordable cancer drugs

Source: Xinhua| 2018-07-24 11:13:17|Editor: Liangyu
Video PlayerClose

BEIJING, July 24 (Xinhua) -- A breast cancer patient surnamed Zhou in a hospital in Chengdu, Sichuan Province, said she is grateful for the reduced costs of cancer drugs.

Zhou said she used to pay over 30,000 yuan (4,500 U.S. dollars) each month for the drug Herceptin. "Since the price dropped and my insurance now reimburses the cost, I feel like a weight has been lifted off my shoulders."

The cost and short supply of cancer drugs have been a longstanding public concern in China.

To alleviate these concerns, the government has introduced policies to address the issue while experts have called on domestic pharmaceutical enterprises to invest more in research and innovation and make more cancer drugs available for the patients.

PRICE REDUCED

From May 1, import tariffs have been lifted on all common drugs including cancer drugs and cancer alkaloid-based drugs.

This is one of the government's latest efforts to make medical care more affordable and accessible to citizens.

In July 2017, the country included 15 tumor-targeting medicines into its list of medically insured drugs and reduced their prices. The list covers a majority of the most frequently used cancer drugs.

Prices of some medicines have dropped remarkably. In Hunan Province, the price of each vial of Herceptin decreased from 17,600 yuan to 7,600 yuan, and the price of each vial of Fulvestrant, also used to treat breast cancer, dropped from 11,500 yuan to 4,800 yuan.

The newly-formed State Medical Insurance Administration said it would further cut the price of cancer drugs on the list via public bidding and procurement.

And medical insurance institutions and pharmaceutical enterprises should negotiate before more cancer medicines, currently not on the list, are included and covered by the insurance.

Meanwhile, the State Drug Administration (SDA) is expediting the approval of cancer drugs. For example, the approval of the marketing of human papillomavirus (HPV) 9-valent vaccine was shortened to just eight days.

According to Jiao Hong, head of the SDA, the administration will fast-track more imported cancer medicines for approval so these medicines can enter China one to two years earlier.

INNOVATION NEEDED

With the prices of cancer drugs substantially declining, demands are exploding nationwide, resulting in a shortage of some drugs in a few areas.

"The key to minimizing cost and reliance on imported cancer drugs is to raise our capability in research and development," said Zeng Yixin, vice director of the National Health Commission.

Data published by the National Cancer Center (NCC) showed that China saw 3.8 million new cases of malignant tumors and 2.3 million cancer-related deaths in 2014.

"Such a large population of cancer patients cannot rely solely on imported cancer medicines," said Shi Yuankai, deputy director of NCC. "China must advance the innovation capacity of its own pharmaceutical enterprises to meet the demand."

China has more than 4,000 pharmaceutical producers, of which over 90 percent produce generic drugs.

With policies to encourage drug research and innovation in recent years, China is forging ahead to make innovative drugs.

Independently developed domestic drugs, such as lung cancer-targeting drug Conmana and gastric cancer-targeting drug Apatinib, now offer a cheaper alternative to the more expensive imported drugs

In June, HYML-122, a drug targeting acute myeloid leukemia, was approved by the SDA for a clinical trial. It was developed by a research team from Hefei Institute of Physical Science. If the trial is successful, the drug will be put into clinical use in five years.

Liu Qingsong, the team leader, said they are striving to make cancer as controllable as chronic diseases like high blood pressure and diabetes. "Our goal is to enable cancer patients to live a normal and fulfilling life."

TOP STORIES
EDITOR’S CHOICE
MOST VIEWED
EXPLORE XINHUANET
010020070750000000000000011100001373447391
主站蜘蛛池模板: 国产69精品福利视频| 欧美日韩三区二区| 久久国产这里只有精品| 九九视频69精品视频秋欲浓| 热久久一区二区| 日韩精品中文字幕在线播放| 国产精品视频1区| 欧美一区二区三区久久精品| 一区二区三区欧美视频| av国产精品毛片一区二区小说| 夜夜夜夜夜猛噜噜噜噜噜gg| 93久久精品日日躁夜夜躁欧美| 中文字幕一区二区三区乱码视频 | 欧美日韩精品在线播放| 精品国产乱码久久久久久免费| 一区二区在线不卡| 欧美一区二区三区高清视频| 国产jizz18女人高潮| 精品久久久久一区二区| 91麻豆精品国产91久久久无限制版| 激情久久综合网| 国产欧美一区二区三区四区| 久久久久久中文字幕| 一区二区在线视频免费观看| 日本xxxx护士高潮hd| 国产欧美一二三区| 欧美日韩偷拍一区| 国产一区二区手机在线观看| 久久99亚洲精品久久99果| 狠狠色丁香久久婷婷综合丁香| 99久精品视频| 国产精品一区二区不卡| 久久99精品国产99久久6男男 | 99久久夜色精品| 亚洲精品国产综合| 国产视频一区二区视频| 亚洲国产视频一区二区三区| 国产福利一区在线观看| 国产伦精品一区二区三区无广告| 久久激情图片| 91精品一区在线观看| 91精品国产综合久久婷婷香| 91av精品| 女人被爽到高潮呻吟免费看| 色妞妞www精品视频| 久久免费视频一区| 性刺激久久久久久久久九色| 91久久一区二区| 国产精一区二区| 国产精品乱码久久久久久久| 国产白丝一区二区三区| 国产中文字幕一区二区三区| 欧美一区二区三区免费观看视频| 免费看性生活片| 国产中文字幕一区二区三区 | 国产一区2| 日本免费电影一区二区| 99国产精品一区二区| 欧美激情精品一区| 国内久久久| 国产乱一乱二乱三| 久久夜色精品国产噜噜麻豆| 91精品一区| 精品国产一二三四区| 亚洲精品少妇一区二区 | 51区亚洲精品一区二区三区| 久久99精品国产麻豆婷婷| 国产精品日韩高清伦字幕搜索| 欧美日韩国产精品一区二区三区| 国产不卡一二三区| 欧美精品粉嫩高潮一区二区| 亚洲自拍偷拍中文字幕| 国产精品刺激对白麻豆99 | 国产一级自拍片| 欧美日韩国产在线一区二区三区| 日本一区二区三区免费视频| 国产91高清| 大bbw大bbw超大bbw| 日本一二三四区视频| 欧美日韩一区二区三区不卡| 欧美午夜一区二区三区精美视频| 欧美一区二区三区片|